TrademarkDir
GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT
LIVE

Serial Number

87660522

Owner

Genesis Drug Discovery & Development, LLC

Attorney

Christina E. Brule

Filing Date

Oct 26, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT Trademark

Serial Number: 87660522 • Registration: 6396881

GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT is a trademark filed by Genesis Drug Discovery & Development, LLC on October 26, 2017. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Genesis Drug Discovery & Development, LLC (14 trademarks)

2439 Kuser Road
Hamilton, NJ 08690

Entity Type: 16

Trademark Details

Filing Date

October 26, 2017

Registration Date

June 22, 2021

Published for Opposition

March 17, 2020

Goods & Services

Scientific study and research in the fields of medicine, the prevention and treatment of illness, drug screening, mode of action of medicines in animal models, and pharmacokinetic evaluation and preclinical evaluation of lead compounds in drug discovery

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 22, 2026 REM1
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 15, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2023 REAP
REGISTERED-PRINCIPAL REGISTER
Jun 22, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 18, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 17, 2021 CNPR
ASSIGNED TO EXAMINER
Apr 30, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 28, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 21, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 2, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 2, 2020 GNRT
SU - NON-FINAL ACTION - WRITTEN
Nov 2, 2020 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Oct 31, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 31, 2020 AITU
USE AMENDMENT FILED
Oct 16, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 16, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 12, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 10, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 3, 2020 ERFR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 14, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 14, 2020 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 1, 2019 GNFN
FINAL REFUSAL E-MAILED
Nov 1, 2019 GNFR
FINAL REFUSAL WRITTEN
Nov 1, 2019 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 10, 2019 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 28, 2019 RCSC
ASSIGNED TO LIE
Mar 26, 2019 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 6, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 6, 2018 GNSL
SUSPENSION LETTER WRITTEN
Sep 6, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 17, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2018 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2018 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2018 CNRT
ASSIGNED TO EXAMINER
Feb 6, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 7, 2017 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2017 NWOS
NEW APPLICATION ENTERED
Oct 30, 2017 NWAP

Related Trademarks

More from this Owner

IMMUNOVEDA logo

IMMUNOVEDA

IMMUNOVEDA logo

IMMUNOVEDA

IMMUNOVEDA

IMMUNOVEDA

IMMUNOVEDA

IMMUNOVEDA

IMMUNOVEDA

IMMUNOVEDA

IMMUNOVEDA logo

IMMUNOVEDA